immunogenicity of 23-valent pneumococcal vaccine in children with systemic lupus erythematosus
Authors
abstract
background: systemic lupus erythematosus (sle) is a chronic autoimmune disease which is characterized by b-cell abnormality and auto-antibody generation. since bacterial infections are the most important causes of mortality in these patients, pneumococcal vaccination is recommended for children with sle. objective: to investigate humoral immunity and specific-antibody formation in response to a 23-valent polysaccharide pneumococcal vaccination in sle children and asthmatic control group. method: the case and control groups consisted of 30 children with the mean age of 13 years who were matched by sex and age. anti-pneumococcal antibody titers were determined using enzyme-linked immunosorbent assay (elisa) before the vaccination with the 23-valent pneumococcal vaccine and 3 weeks later in both groups. also the correlation between anti-pneumococcal antibody titer and different factors including age, sex, lupus activity, disease duration, medications, history of recurrent infections, and laboratory data were investigated. results: both groups showed significant increases in anti-pneumococcal antibody level after vaccination (p≤0.001). the increase in antibody level were almost the same in both groups (p≥0.05) such that 77.7% of sle children and 86.2% of control children showed at least 2-fold increase in anti-pneumococcal antibody titer following immunization. significant correlations were seen between the level of post-immunization anti-pneumococcal antibody with the age of children with sle (p=0.02) and their age of disease onset (p=0.02). conclusion: it is concluded that pneumococcal vaccination is generally immunogenic in children with sle. however, a small group of patients show impaired response to the vaccine.
similar resources
Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus
Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease which is characterized by B-cell abnormality and auto-antibody generation. Since bacterial infections are the most important causes of mortality in these patients, pneumococcal vaccination is recommended for children with SLE. Objective: To investigate humoral immunity and specific-antibody formation in response to a...
full textImmunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus.
BACKGROUND Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease which is characterized by B-cell abnormality and auto-antibody generation. Since bacterial infections are the most important causes of mortality in these patients, pneumococcal vaccination is recommended for children with SLE. OBJECTIVE To investigate humoral immunity and specific-antibody formation in response to a...
full textImmunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine.
There is still a lack of effective vaccination strategies for patients with a deficient antibody response to bacterial polysaccharide antigens. In an open trial, we evaluated the immunogenicity and tolerance of a new 7-valent pneumococcal conjugate vaccine in 22 infection-prone nonresponders to pneumococcal polysaccharide vaccine and 21 controls. In the patient group, nonresponsiveness was conf...
full textCutaneous Manifestations of Systemic Lupus Erythematosus in Iranian Children
Systemic lupus erythematous (SLE) is an autoimmune process in which cutaneous lesions occur in majority of patients. This study was conducted to determine the pattern and prevalence of such lesions in SLE in Iranian children infected with SLE. Forty-eight patients, age between 3-16 yrs and male to female ratio of 7/1 were examined for the presence of cutaneous manifestations of SLE. The most co...
full textImmunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
BACKGROUND Streptococcus pneumoniae is a major cause of morbidity and mortality among adults 50 years of age and older in the United States. Pneumococcal conjugate vaccines are efficacious against pneumococcal disease in children and may also offer advantages in adults. METHODS We performed a randomized, modified double-blind trial that compared a single dose of 13-valent pneumococcal conjuga...
full textNeurobrucellosis in systemic lupus erythematosus
Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of immunologyجلد ۱۳، شماره ۳، صفحات ۲۰۴-۲۱۹
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023